title: Ocular melanoma.
abstract: Ocular melanomas comprise uveal and conjunctival sub-types, which are very different from each other. A large majority of uveal melanomas involve the choroid, with less than 10% being confined to the ciliary body and iris. They tend to metastasize haematogenously, almost always involving the liver. Therapeutic methods include various forms of radiotherapy, surgical resection and phototherapy, which are often used in combination. Conjunctival melanomas show many similarities to their cutaneous counterparts, often metastasizing by lymphatic spread. Treatment consists of excision of invasive melanoma with adjunctive radiotherapy and/or cryotherapy and topical chemotherapy for intra-epithelial disease. The management of patients with ocular melanomas demands a good understanding of the pathology of these tumours. Pathological examination of the tumour indicates the prognosis and hence the need for further investigation and treatment. The scope of the pathologist is enhanced thanks to advances in molecular biology.
authors: Liverpool Ocular Oncology Service, Royal Liverpool University Hospital, Liverpool, UK.
authors: Bertil E
authors: BE
authors: Damato
authors: Sarah E
authors: SE
authors: Coupland
keywords: Conjunctiva; Eye; Melanoma; Pathology; Uvea
references: Acta Ophthalmol. 2011 Mar;89(2):e155-60
references: 19900200
references: Am J Ophthalmol. 2005 Oct;140(4):748-9
references: 16226537
references: Ophthalmology. 2009 Nov;116(11):2217-23
references: 19766318
references: Ophthalmology. 2011 Feb;118(2):389-95.e1-2
references: 20723990
references: J Cutan Pathol. 2011 Jan;38(1):18-24
references: 20860727
references: Genes Chromosomes Cancer. 2001 Mar;30(3):267-73
references: 11170284
references: Clin Exp Ophthalmol. 2008 Nov;36(8):786-95
references: 19128387
references: Future Oncol. 2011 Mar;7(3):435-46
references: 21417906
references: Science. 2010 Dec 3;330(6009):1410-3
references: 21051595
references: Ophthalmology. 2011 Nov;118(11):2307-8; author rpely 3208-9
references: 22047898
references: Clin Cancer Res. 2010 Dec 15;16(24):6083-92
references: 20975103
references: Ophthalmology. 2007 Oct;114(10):1925-31
references: 17719643
references: Br J Ophthalmol. 2008 Nov;92(11):1545-9
references: 18669542
references: Am J Ophthalmol. 1978 Oct;86(4):557-64
references: 707604
references: Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1008-11
references: 12601021
references: Cancer. 1998 Jul 15;83(2):354-9
references: 9669819
references: Ophthalmology. 2008 Oct;115(10):1778-85
references: 18554722
references: J Mol Diagn. 2010 Jul;12(4):461-8
references: 20413675
references: Ophthalmol Clin North Am. 2005 Mar;18(1):75-84, viii
references: 15763193
references: Ophthalmology. 2011 Dec;118(12):2351-60
references: 21835473
references: Graefes Arch Clin Exp Ophthalmol. 2007 Mar;245(3):431-6
references: 16941140
references: Lancet. 1996 May 4;347(9010):1222-5
references: 8622452
references: Cancer Res. 1999 Jul 1;59(13):3032-7
references: 10397238
references: Acta Ophthalmol. 2012 Sep;90(6):534-9
references: 21114636
references: Surv Ophthalmol. 1998 Jan-Feb;42(4):321-50
references: 9493274
references: Prog Retin Eye Res. 2011 Sep;30(5):285-95
references: 21658465
references: Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5598-604
references: 21693616
references: Eye (Lond). 2012 Feb;26(2):292-9
references: 22079972
references: Arch Pathol Lab Med. 2009 Aug;133(8):1197-8
references: 19653708
references: Ophthalmology. 2004 Apr;111(4):816-21
references: 15051218
references: Hum Pathol. 1985 Feb;16(2):129-35
references: 3972395
references: Acta Ophthalmol. 2011 Feb;89(1):17-24
references: 21272286
references: Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4651-9
references: 14578381
references: Pigment Cell Melanoma Res. 2012 Mar;25(2):171-81
references: 22268848
references: Eye (Lond). 2009 Apr;23(4):801-9
references: 18535601
references: Br J Ophthalmol. 1994 Apr;78(4):252-9
references: 8199108
references: Ophthalmology. 2001 Jan;108(1):172-8
references: 11150284
references: Clin Cancer Res. 2012 Jan 1;18(1):9-14
references: 22083257
references: Cancer Genet Cytogenet. 2000 Oct 1;122(1):13-7
references: 11104026
references: Future Oncol. 2011 Jan;7(1):101-9
references: 21174541